Acadia pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that on september 23, 2024, the board of directors granted catherine owen adams, acadia's new chief executive officer, a one-time sign-on equity award of (i) 353,261 options to purchase shares of acadia's common stock with an exercise price of $16.29 per share, acadia's closing trading price on september 23, 2024, which vest 25% on the first anniversary of grant and in equal monthly installments over the thre.
ACAD Ratings Summary
ACAD Quant Ranking